Language of document :

Appeal brought on 18 January 2021 by Dermavita Co. Ltd against the judgment of the General Court (Third Chamber) delivered on 18 November 2020 in Case T-643/19, Dermavita v EUIPO – Allergan Holdings France (JUVEDERM ULTRA)

(Case C-26/21 P)

Language of the case: English


Appellant: Dermavita Co. Ltd (represented by: D. Todorov, advokat)

Other parties to the proceedings: European Union Intellectual Property Office (EUIPO), Allergan Holdings France SAS

By order of 4 May 2021, the Court of Justice (Chamber determining whether appeals may proceed) held that the appeal was not allowed to proceed and that Dermavita Co. Ltd should bear its own costs.